| NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors (NCT05252390) | Nuvation Bio Inc. | 2022-03-29 |
| 68Ga-labeled NY108 PET Imaging in Patients (NCT05623878) | Affiliated Hospital of Jiangnan University | 2022-01-04 |
| [68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer (NCT04484701) | British Columbia Cancer Agency | 2021-02-01 |
| Safety and Feasibility of Reversible Induction Strategy (NCT04434963) | RenJi Hospital | 2021-02-01 |
| Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors (NCT04541225) | Nuvation Bio Inc. | 2020-12-08 |
| Quadratus Lumborum Block vs Transversus Abdominis Plane Block for Post-prostatectomy Analgesia (NCT03606889) | Jagiellonian University | 2018-07-31 |
| Treatment of Castration Resistant Prostate Cancer Using Multi-Targeted Recombinant Ad5 PSA/MUC1/Brachyury Based Immunotherapy Vaccines (NCT03481816) | National Cancer Institute (NCI) | 2018-07-24 |
| Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer (NCT03354416) | National Cancer Institute (NCI) | 2018-02-26 |
| Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy (NCT03388619) | National Cancer Institute (NCI) | 2018-01-17 |
| Prostate Cancer Risk in Firefighters (NCT03893123) | Oslo University Hospital | 2018-01-01 |
| 18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer (NCT03181867) | National Cancer Institute (NCI) | 2017-08-03 |
| 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer (NCT03173924) | National Cancer Institute (NCI) | 2017-06-06 |
| Clinical Trial to Examine Individual Pain Tolerance in the Use of Two Anesthetic Techniques to Perform Saturation Prostate Biopsy (NCT02909049) | Complexo Hospitalario Universitario de A Coruña | 2016-04-01 |
| Open Anterograde Radical Prostatectomy Compared to Open Retrograde Technique (NCT02687308) | Rio de Janeiro State University | 2016-03-01 |
| Optimizing the Effectiveness of Routine Post-treatment Surveillance in Prostate Cancer Survivors (NCT02957357) | Alliance Foundation Trials, LLC. | 2016-02-01 |
| Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer (NCT02349139) | Asana BioSciences | 2015-01-19 |
| Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer (NCT02334579) | Swedish Medical Center | 2014-12-01 |
| Prothrombotic Factors and Anaesthesia in Prostate Cancer (NCT01998685) | Regina Elena Cancer Institute | 2013-06-01 |
| Sipuleucel-T Manufacturing Demonstration Study (NCT01477749) | Dendreon | 2012-06-01 |
| Metabolic Changes in Prostate Cancer Patients With Androgen-ablation Therapy (AAT) (NCT01284608) | AstraZeneca | 2011-03-01 |
| North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS) (NCT02564120) | UNC Lineberger Comprehensive Cancer Center | 2011-01-01 |
| To Evaluate the Technique and Effects of Separating the Prostate and Rectum With Hyaluronic Acid During Radiotherapy (NCT01787630) | Anders Widmark | 2010-01-01 |
| Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer (NCT00970203) | Roswell Park Cancer Institute | 2009-09-01 |
| Effect of Adding Sufentanil to Epidural Ropivacaine on Perioperative Metabolic and Stress Responses in Combined General/Epidural Anaesthesia for Geriatric Radical Retropubic Prostatectomy (NCT01086956) | Yonsei University | 2008-09-01 |
| CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution (NCT00643994) | Accuray Incorporated | 2007-12-01 |
| CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry (NCT00643617) | Accuray Incorporated | 2007-10-22 |
| Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors (NCT00511576) | Mirati Therapeutics Inc. | 2007-08-01 |
| Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer (NCT00417274) | Cleveland BioLabs | 2006-12-01 |
| Autologous Dendritic Cell Therapy for Hormone-Refractory Metastatic Prostate Cancer (NCT01171729) | Samsung Medical Center | 2006-07-01 |
| A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy (NCT00257478) | Astellas Pharma Inc | |